Cargando…
Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report
RATIONALE: Hydroxychloroquine has excellent anti-inflammatory and immunomodulatory effects as one of the antimalarial drugs. In particular, hydroxychloroquine was once widely used as a treatment for the new coronavirus pneumonia epidemic in 2020. Retinopathy caused by hydroxychloroquine is normally...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183791/ https://www.ncbi.nlm.nih.gov/pubmed/34087822 http://dx.doi.org/10.1097/MD.0000000000025688 |
_version_ | 1783704444573057024 |
---|---|
author | Wang, Gang Zhuo, Ning Liao, Zheng Qi, Wei Tian, Feng Wen, Zhenhua Li, Jingyang |
author_facet | Wang, Gang Zhuo, Ning Liao, Zheng Qi, Wei Tian, Feng Wen, Zhenhua Li, Jingyang |
author_sort | Wang, Gang |
collection | PubMed |
description | RATIONALE: Hydroxychloroquine has excellent anti-inflammatory and immunomodulatory effects as one of the antimalarial drugs. In particular, hydroxychloroquine was once widely used as a treatment for the new coronavirus pneumonia epidemic in 2020. Retinopathy caused by hydroxychloroquine is normally irreversible, but little attention has been paid to it. PATIENT CONCERNS: A 38-year-old young Chinese woman was taking oral hydroxychloroquine 400 mg daily to control lupus disease activity for six years after the diagnosis of systemic lupus erythematosus (SLE). She did not have any history of eye disease and was admitted to the hospital with a sudden blurring of both eyes. DIAGNOSES: The diagnosis of retinal macular degeneration caused by hydroxychloroquine was made after excluding other interfering diseases based on the patient's long-term use of hydroxychloroquine and the results of the eye examination. INTERVENTIONS: The patient was discontinued from hydroxychloroquine. To control the recurrence of SLE, she was given intravenous methylprednisolone, oral tacrolimus and mycophenolate. Meanwhile, she was asked to take extra care of her eyes and to come to the hospital every three months to have her vision checked. OUTCOMES: The patient's blurred vision improved one week later. Three months later, her vision examination showed no further decline (0.4 in the right eye and 0.6 in the left eye). Meanwhile, the SLE disease activity index (SLEDAI) decreased from six points to five points currently. LESSONS: Retinopathy caused by hydroxychloroquine is irreversible and there is no particularly effective treatment. Discontinuation of hydroxychloroquine, better daily eye protection, and regular vision checks are the keys to preventing retinopathy. Although hydroxychloroquine causing retinal toxicity was mentioned several years ago, the rate and severity of retinal toxicity require further research. How to get more patients to take care of their eyes requires continuous and increased education by doctors. |
format | Online Article Text |
id | pubmed-8183791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81837912021-06-07 Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report Wang, Gang Zhuo, Ning Liao, Zheng Qi, Wei Tian, Feng Wen, Zhenhua Li, Jingyang Medicine (Baltimore) 6900 RATIONALE: Hydroxychloroquine has excellent anti-inflammatory and immunomodulatory effects as one of the antimalarial drugs. In particular, hydroxychloroquine was once widely used as a treatment for the new coronavirus pneumonia epidemic in 2020. Retinopathy caused by hydroxychloroquine is normally irreversible, but little attention has been paid to it. PATIENT CONCERNS: A 38-year-old young Chinese woman was taking oral hydroxychloroquine 400 mg daily to control lupus disease activity for six years after the diagnosis of systemic lupus erythematosus (SLE). She did not have any history of eye disease and was admitted to the hospital with a sudden blurring of both eyes. DIAGNOSES: The diagnosis of retinal macular degeneration caused by hydroxychloroquine was made after excluding other interfering diseases based on the patient's long-term use of hydroxychloroquine and the results of the eye examination. INTERVENTIONS: The patient was discontinued from hydroxychloroquine. To control the recurrence of SLE, she was given intravenous methylprednisolone, oral tacrolimus and mycophenolate. Meanwhile, she was asked to take extra care of her eyes and to come to the hospital every three months to have her vision checked. OUTCOMES: The patient's blurred vision improved one week later. Three months later, her vision examination showed no further decline (0.4 in the right eye and 0.6 in the left eye). Meanwhile, the SLE disease activity index (SLEDAI) decreased from six points to five points currently. LESSONS: Retinopathy caused by hydroxychloroquine is irreversible and there is no particularly effective treatment. Discontinuation of hydroxychloroquine, better daily eye protection, and regular vision checks are the keys to preventing retinopathy. Although hydroxychloroquine causing retinal toxicity was mentioned several years ago, the rate and severity of retinal toxicity require further research. How to get more patients to take care of their eyes requires continuous and increased education by doctors. Lippincott Williams & Wilkins 2021-06-04 /pmc/articles/PMC8183791/ /pubmed/34087822 http://dx.doi.org/10.1097/MD.0000000000025688 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 6900 Wang, Gang Zhuo, Ning Liao, Zheng Qi, Wei Tian, Feng Wen, Zhenhua Li, Jingyang Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title | Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title_full | Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title_fullStr | Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title_full_unstemmed | Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title_short | Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report |
title_sort | retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: a case report |
topic | 6900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183791/ https://www.ncbi.nlm.nih.gov/pubmed/34087822 http://dx.doi.org/10.1097/MD.0000000000025688 |
work_keys_str_mv | AT wanggang retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT zhuoning retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT liaozheng retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT qiwei retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT tianfeng retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT wenzhenhua retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport AT lijingyang retinaltoxicitycausedbyhydroxychloroquineinpatientswithsystemiclupuserythematosusacasereport |